1. Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs

   • Dixon Thomas
   • Zoya Ali
   • Jason C. Cooper

   Current Opinion 28 March 2017 Pages: 343 - 346

2. Teaching an Old Dog New Tricks: Colchicine in Cardiovascular Medicine

   • Kevin Chen
   • Aldo L. Schenone
   • Venu Menon

   Review Article 28 March 2017 Pages: 347 - 360

   

3. The Real Role of β-Blockers in Daily Cardiovascular Therapy

   • Csaba András Dézsi
   • Veronika Szentes

   Review Article Open access 29 March 2017 Pages: 361 - 373

4. Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications

   • Barbara S. Wiggins
   • Donald G. Lamprecht Jr.
   • Joseph J. Saseen

   Review Article 01 April 2017 Pages: 375 - 389

   

5. Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice

   • Charalampos I. Liakos
   • Dimitrios P. Papadopoulos
   • Vasilios T. Kotsis

   Original Research Article 02 May 2017 Pages: 391 - 398

   

6. The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin

   • Andrej Janzic
   • Igor Locatelli
   • Mitja Kos

   Original Research Article 20 May 2017 Pages: 399 - 408

   

7. The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy

   • Shigemasa Tani
   • Ken Nagao
   • Atsushi Hirayama

   Original Research Article 20 June 2017 Pages: 409 - 420